Loading…
Bridge to Life Ltd. acquired the VitaSmart Hypothermic Oxygenated Machine Perfusion System from Medica S.p.A., including exclusive global trademark rights. The deal strengthens Bridge to Life's position in organ preservation.
TransMedics Group has acquired from Bridge to Life Ltd. the assets and intellectual property related to the EVOSS warm perfusion technology and LifeCradle cold perfusion technology for organ transplantation.
Bridge to Life, a supplier of organ preservation solutions, and Tevosol, a medical device startup, announced their merger to develop and commercialize Tevosol's portable ex-vivo lung perfusion machine and normothermic organ preservation platform. The merger was announced on February 9, 2021.